Literature DB >> 18407909

Covert assessment of concurrent and construct validity of a chart to characterize fecal output and diarrhea in patients receiving enteral nutrition.

Kevin Whelan1, Patricia A Judd, Victor R Preedy, Moira A Taylor.   

Abstract

BACKGROUND: An accurate and convenient method for characterizing fecal output and a consistent threshold for classifying diarrhea in patients receiving enteral nutrition are required. The aim of this study is to covertly assess the construct and concurrent validity of a chart for characterizing fecal output and classifying diarrhea in patients receiving enteral nutrition.
METHODS: The chart was used to monitor fecal output in patients receiving enteral nutrition for a total of 280 patient days. Nurses characterized 291 fecal samples, of which 84 underwent measurement of fecal water using lyophilization and 60 underwent Clostridium difficile enterotoxin analysis using enzyme-linked immunosorbent assay. Construct and concurrent validity was assessed covertly to measure the true performance of the chart in a real-life clinical and research context.
RESULTS: Use of the chart demonstrated higher fecal frequency (P <or= .04), heavier stools (P <or= .167), more unformed stools (P <or= .001), higher daily fecal scores (P <or= .001), and higher incidence of diarrhea (P <or= .002) on days when patients had severe hypoalbuminemia, were receiving antibiotics, or had a recent positive C difficile assay, demonstrating construct validity. The water content of samples assigned to hard and formed (62.0%), soft and formed (72.1%), loose and unformed (79.3%), and liquid (87.9%) categories was significantly different (P < .001), demonstrating concurrent validity.
CONCLUSIONS: Under covert assessment, the chart demonstrated construct validity for characterizing fecal output, daily fecal score, and diarrhea, together with concurrent validity for characterizing fecal consistency. Use of the chart in clinical practice and research will standardize the characterization of fecal output and classification of diarrhea in patients receiving enteral nutrition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407909     DOI: 10.1177/0148607108314769

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  3 in total

1.  Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.

Authors:  So Ra Yoon; Jong Hwa Lee; Jae Hyang Lee; Ga Yoon Na; Kyun-Hee Lee; Yoon-Bok Lee; Gu-Hun Jung; Oh Yoen Kim
Journal:  Nutr J       Date:  2015-11-03       Impact factor: 3.271

2.  Comparison of efficacy of Saccharomyces boulardii strain in the treatment of acute diarrhea in children: A prospective, single-blind, randomized controlled clinical trial.

Authors:  Meeta Amit Burande
Journal:  J Pharmacol Pharmacother       Date:  2013-07

3.  Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome.

Authors:  P Marquis; K E Lasch; L Delgado-Herrera; S Kothari; A Lembo; C Lademacher; G Spears; A Nishida; Waldman L Tesler; E Piault; K Rosa; B Zeiher
Journal:  Clin Transl Gastroenterol       Date:  2014-06-26       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.